Aclaris Therapeutics Reports Fourth Quarter and Full Year 2015 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. FDX
4. META
5. ABBV
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Aclaris Therapeutics Reports Fourth Quarter and Full Year 2015 Operating and Financial Results

Aclaris Therapeutics (ACRS) Reports Q4 Loss of $0.28/Share

March 23, 2016 4:04 PM EDT

Aclaris Therapeutics (NASDAQ: ACRS) reported Q4 EPS of ($0.28), versus ($1.76) reported last year.

For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.

... More